LncRNA JHDM1D-AS1 Suppresses MPP + -Induced Neuronal Injury in Parkinson's Disease via miR-134-5p/PIK3R3 Axis

Neurotox Res. 2021 Dec;39(6):1771-1781. doi: 10.1007/s12640-021-00437-8. Epub 2021 Nov 13.

Abstract

Parkinson's disease (PD) is a multi-factorial neurodegenerative disease. Long noncoding RNAs (lncRNAs) have been revealed to be involved in the process of PD. Herein, this study aimed to investigate the potential function and mechanism of JHDM1D-AS1 (JHDM1D antisense 1) in PD process. 1-Methyl-4-phenylpyridinium (MPP +)-induced SK-N-SH cells were used to conduct expression and function analyses. Levels of genes and proteins were examined using real-time reverse transcription PCR (RT-qPCR) and Western blot. Cell viability and apoptosis were determined using CCK-8 assay, flow cytometry, and Western blot, respectively. ELISA analysis was performed for the detection of interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α. The contents of lactate dehydrogenase (LDH), superoxide dismutase (SOD), and malondialdehyde (MDA) were measured using commercial kits. The direct interactions between miR-134-5p and PIK3R3 (Phosphoinositide-3-Kinase Regulatory Subunit 3) or JHDM1D-AS1 were verified by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. JHDM1D-AS1 expression was decreased by MPP + in SK-N-SH cells in a dose- or time-dependent manner. Functionally, JHDM1D-AS1 overexpression attenuated MPP + -evoked neuronal apoptosis, inflammation, and oxidative stress. Mechanistically, JHDM1D-AS1 competitively bound to miR-134-5p to upregulate the expression of its target PIK3R3. Rescue experiments suggested that miR-134-5p upregulation reversed the inhibitory effects of JHDM1D-AS1 on MPP + -induced neuronal injury. Moreover, inhibition of miR-134-5p protected neurons against MPP + -induced neuronal apoptosis, inflammation, and oxidative stress, which were abolished by PIK3R3 silencing. JHDM1D-AS1 protected against MPP + -induced neuron injury via miR-134-5p/PIK3R3 axis, suggesting the potential involvement of this axis in PD process.

Keywords: JHDM1D-AS1; Oxidative stress; PIK3R3; Parkinson’s disease; miR-134-5p.

MeSH terms

  • 1-Methyl-4-phenylpyridinium / antagonists & inhibitors
  • 1-Methyl-4-phenylpyridinium / pharmacology
  • Blotting, Western
  • Cell Line, Tumor
  • Flow Cytometry
  • Humans
  • Jumonji Domain-Containing Histone Demethylases / metabolism*
  • MicroRNAs / metabolism*
  • Neurons / drug effects*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / metabolism*
  • Phosphatidylinositol 3-Kinases / metabolism*
  • RNA, Long Noncoding / metabolism*
  • Real-Time Polymerase Chain Reaction

Substances

  • MIRN134 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • Jumonji Domain-Containing Histone Demethylases
  • KDM7A protein, human
  • PIK3R3 protein, human
  • 1-Methyl-4-phenylpyridinium